Evidence map›Paper›PMID 41049816›Full record

ArticleAsian journal of urology2025

Optimized graph neural network-multilayer perceptron fusion classifier for metastatic prostate cancer detection in Western and Asian populations.

Fengxian Han, Xiaohui Fan, Pengwei Long, Wenhui Zhang, Qiting Li, Yingxuan Li, Xingpeng Guo, Yinran Luo, Rongqi Wen, Sheng Wang and 5 more

Abstract read
In one paragraph

Article in Asian journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Pathway-guided architectures for interpretable AI in biological research.Computational and structural biotechnology journal · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Fengxian HanSchool of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China.
Xiaohui FanSchool of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China.
Pengwei LongHealth Service Department, Guard Bureau of Joint Staff Department, Beijing, China.
Wenhui ZhangDepartment of Urology, Changhai Hospital, Second Military Medical University (Naval Medical University), Shanghai, China.
Qiting LiSchool of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China.
Yingxuan LiDepartment of Precision Medicine, Changhai Hospital, Second Military Medical University (Naval Medical University), Shanghai, China.
Xingpeng GuoDepartment of Precision Medicine, Changhai Hospital, Second Military Medical University (Naval Medical University), Shanghai, China.
Yinran LuoDepartment of Precision Medicine, Changhai Hospital, Second Military Medical University (Naval Medical University), Shanghai, China.
Rongqi WenDepartment of Precision Medicine, Changhai Hospital, Second Military Medical University (Naval Medical University), Shanghai, China.
Sheng WangDepartment of Precision Medicine, Changhai Hospital, Second Military Medical University (Naval Medical University), Shanghai, China.
Shan ZhangDepartment of Precision Medicine, Changhai Hospital, Second Military Medical University (Naval Medical University), Shanghai, China.
Yizhuo LiDepartment of Oncology, 905th Hospital of PLA Navy Naval Medical University, Shanghai, China.
Yan WangDepartment of Urology, Changhai Hospital, Second Military Medical University (Naval Medical University), Shanghai, China.
Xu GaoDepartment of Urology, Changhai Hospital, Second Military Medical University (Naval Medical University), Shanghai, China.
Jing LiSchool of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Prostate cancer (PCa) exhibits significant genomic differences between Western and Asian populations. This study aimed to design a predictive model applicable across diverse populations while selecting a limited set of genes suitable for clinical implementation. Methods: We utilized an integrated dataset of 1360 whole-exome and whole-genome sequences from Chinese and Western PCa cohorts to develop and evaluate the model. External validation was conducted using an independent cohort of patients. A graph neural network architecture, termed the pathway-aware multi-layered hierarchical network-Western and Asian (P-NETwa), was developed and trained on combined genomic profiles from Chinese and Western cohorts. The model employed a multilayer perceptron (MLP) to identify key signature genes from multi-omics data, enabling precise prediction of PCa metastasis. Results: The model achieved an accuracy of 0.87 and an F1-score of 0.85 on Western population datasets. The application of integrated Chinese and Western population data improved the accuracy to 0.88, achieving an F1-score of 0.75. The analysis identified 18 signature genes implicated in PCa progression, including established markers ( Conclusion: The P-NETwa-MLP model integrates a query system that allows for efficient retrieval of prediction outcomes and associated genomic signatures via sample ID, enhancing its potential for seamless integration into clinical workflows.

Indexed as

Graph neural networkMachine learningMultilayer perceptronProstate cancer

Identifiers

PMID41049816
PMCPMC12490683

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.